“We had a cure rate of 96% in patients with squamous cell carcinoma and 98% in patients with basal cell carcinoma, and cosmetic outlook was

“Our study shows that age is an important factor to consider when administering immunotherapy to melanoma patients,” said Ashani Weeraratna,